circle

INVESTORS & MEDIA

PRESS RELEASES

There are currently no events to display.

Keyword Search

Press Release Archive 1998-2005
Date Title  
March 6, 2023
Cytokinetics to Participate in Upcoming Investor Conferences
link
March 4, 2023
Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session
link
March 2, 2023
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
link
March 1, 2023
Cytokinetics Reports Fourth Quarter 2022 Financial Results
link
February 28, 2023
Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil
link
February 24, 2023
Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session
link
February 22, 2023
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
link
February 15, 2023
Cytokinetics to Announce Fourth Quarter Results on March 1, 2023
link
February 1, 2023
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
link
January 30, 2023
Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program
link
January 4, 2023
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
link
January 3, 2023
Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
link